LICA PHARMACEUTICALS A/S — Credit Rating and Financial Key Figures
CVR number: 25332520
Tuborg Havnepark 2, 2900 Hellerup
ak@kharazmi.dk
tel: 40107500
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 279.65 | 326.21 | 370.72 | 312.60 | 234.22 |
| EBIT | 279.65 | 326.21 | 370.72 | 312.60 | 234.22 |
| Other financial income | 2 153.21 | 772.35 | 2 943.68 | 372.39 | 2 014.58 |
| Other financial expenses | -51.28 | -10.76 | -24.14 | -2 634.36 | -24.40 |
| Pre-tax profit | 2 381.59 | 1 087.81 | 3 290.26 | -1 949.37 | 2 224.41 |
| Income taxes | 400.70 | - 244.19 | - 726.46 | 424.59 | - 493.34 |
| Net earnings | 2 782.29 | 843.62 | 2 563.81 | -1 524.79 | 1 731.07 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current loans receivable | 17 552.58 | 18 118.27 | 20 230.29 | 17 727.72 | 21 123.47 |
| Long term receivables total | 17 552.58 | 18 118.27 | 20 230.29 | 17 727.72 | 21 123.47 |
| Inventories total | |||||
| Current trade debtors | 139.57 | 164.03 | 114.95 | 95.25 | 62.30 |
| Current amounts owed by group member comp. | 448.80 | 485.65 | 485.65 | 442.33 | 519.01 |
| Current deferred tax assets | 419.35 | 176.47 | 22.23 | 523.50 | 13.17 |
| Short term receivables total | 1 007.72 | 826.15 | 622.83 | 1 061.08 | 594.49 |
| Cash and bank deposits | 331.37 | 792.99 | 1 446.42 | 1 940.99 | 729.86 |
| Cash and cash equivalents | 331.37 | 792.99 | 1 446.42 | 1 940.99 | 729.86 |
| Balance sheet total (assets) | 18 891.66 | 19 737.40 | 22 299.54 | 20 729.79 | 22 447.82 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 500.55 | 500.55 | 500.55 | 500.55 | 500.55 |
| Retained earnings | 15 467.22 | 18 249.50 | 19 093.12 | 21 656.93 | 20 132.14 |
| Profit of the financial year | 2 782.29 | 843.62 | 2 563.81 | -1 524.79 | 1 731.07 |
| Shareholders equity total | 18 750.05 | 19 593.67 | 22 157.48 | 20 632.69 | 22 363.76 |
| Non-current liabilities total | |||||
| Current trade creditors | 19.50 | 19.90 | 19.90 | 19.50 | 19.83 |
| Short-term deferred tax liabilities | 43.32 | ||||
| Other non-interest bearing current liabilities | 122.11 | 123.83 | 78.84 | 77.60 | 64.23 |
| Current liabilities total | 141.61 | 143.73 | 142.06 | 97.10 | 84.06 |
| Balance sheet total (liabilities) | 18 891.66 | 19 737.40 | 22 299.54 | 20 729.79 | 22 447.82 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.